<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Metabolism is again emerging as a key property that differentiates <z:mpath ids='MPATH_458'>normal</z:mpath> cells from neoplastic tissues </plain></SENT>
<SENT sid="1" pm="."><plain>The coupling of this phenomenon with advanced bioanalytic methods may now open new avenues for diagnostics in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> via discovery of chemical biomarkers </plain></SENT>
<SENT sid="2" pm="."><plain>In this issue of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Prevention Research, Montrose and colleagues apply metabolic profiling to a model of chemically induced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and describe the metabolomic landscape of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> and associated biofluids in great detail </plain></SENT>
<SENT sid="3" pm="."><plain>Their analysis of plasma and fecal metabolites provides inroads into the noninvasive detection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> using biochemical markers, as some conserved metabolic changes were altered across <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, plasma, and feces </plain></SENT>
<SENT sid="4" pm="."><plain>Meanwhile, the specific alterations identified in this study offer insights into potential metabolic drivers of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>For example, elevated <z:chebi fb="0" ids="15611">sarcosine</z:chebi> and <z:chebi fb="0" ids="11596">2-hydroxyglutarate</z:chebi> were detected in these induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, implicating their respective metabolic pathways and downstream interactions in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression </plain></SENT>
<SENT sid="6" pm="."><plain>This work highlights the potential value of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> metabolomics for the noninvasive analysis of colorectal <z:hpo ids='HP_0002664'>neoplasias</z:hpo> while underscoring the importance of profiling diverse sample sets and metabolites in relevant <z:e sem="disease" ids="C1516211" disease_type="Experimental Model of Disease" abbrv="">cancer models</z:e> to identify and validate such findings </plain></SENT>
</text></document>